Screener
Tectonic Therapeutics TECX EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Tectonic Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Tectonic Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:19 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-212016
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Other expense | (113) | (32) |
| Total other income, net | 2,060 | 2,392 |
| Net loss | (25,241) | (15,906) |
| Other comprehensive loss: | ||
| Foreign currency translation adjustment | 37 | (7) |
| Comprehensive loss | $(25,204) | $(15,913) |
| Net loss per share, basic and diluted | $(1.34) | $(0.93) |
| Weighted-average common shares outstanding, basic and diluted | 18,769,004 | 17,157,661 |
Item 1. Financial Statements.
FAQ
- What is Tectonic Therapeutics's EPS (diluted)?
- Tectonic Therapeutics (TECX) reported EPS (diluted) of -$1.34 in Q1 2026.
- How has Tectonic Therapeutics's EPS (diluted) changed year-over-year?
- Tectonic Therapeutics's EPS (diluted) decreased by 44.1% year-over-year, from -$0.93 to -$1.34.
- What is the long-term trend for Tectonic Therapeutics's EPS (diluted)?
- Over 3 years (2021 to 2025), Tectonic Therapeutics's EPS (diluted) has grown at a 13.2% compound annual growth rate (CAGR), from -$2.79 to -$4.05.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Tectonic Therapeutics's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude